S Todo
Overview
Explore the profile of S Todo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
687
Citations
7877
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imashuku S, Ikushima S, Esumi N, Todo S, Saito M
Leuk Lymphoma
. 2016 Jul;
3(4):287-92.
PMID: 27464249
Serum levels of interferon (IFN)-gamma, cytotoxic factor (CF) and soluble interleukin-2 receptor (sIL2R) were assayed in relation to hyperferritinemia in eleven cases of malignant histiocytosis (MH), seven of virus-associated hemophagocytic...
2.
Taguchi M, Chainani A, Ueda S, Matsunami M, Ishida Y, Eguchi R, et al.
Phys Rev Lett
. 2016 Jan;
115(25):256405.
PMID: 26722935
We study the electronic structure of bulk single crystals and epitaxial films of Fe_{3}O_{4}. Fe 2p core level spectra show clear differences between hard x-ray (HAX) and soft x-ray photoemission...
3.
Yoshida T, Yamashita K, Watanabe M, Koshizuka Y, Kuraya D, Ogura M, et al.
Am J Transplant
. 2015 May;
15(10):2565-75.
PMID: 26012352
Unpreventable allograft rejection is one of the main problems in pancreatic islet transplantation (PIT). Therefore, it is imperative to develop a more effective immunosuppressive strategy. The blockade of transcription factors...
4.
Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, et al.
Surg Technol Int
. 2015 May;
2:165-70.
PMID: 25951558
Since the advent of the potent immunosuppressive agent FK 506, intestinal transplantation has become a feasible therapeutic option for patients with irreversible intestinal failure. In this chapter, we present our...
5.
Marino I, Tzakis A, Fung J, Todo S, Doyle H, Manez R, et al.
Surg Technol Int
. 2015 May;
2:139-44.
PMID: 25951555
During the past 30 years orthotopic liver transplantation has become a highly successful form of surgical treatments. The significant advances achieved in this field have led to an increased demand...
6.
Nakahashi S, Furukawa H, Shimamura T, Todo S, Gando S
Anaesth Intensive Care
. 2014 Jan;
42(1):138-40.
PMID: 24471678
No abstract available.
7.
Watanabe M, Yamashita K, Suzuki T, Kamachi H, Kuraya D, Koshizuka Y, et al.
Am J Transplant
. 2013 Jul;
13(8):1976-88.
PMID: 23841873
A strategy for inhibiting CD40 has been considered as an alternative approach for immunosuppression because of undesirable effects of anti-CD154 monoclonal antibodies (mAbs). Previously, we demonstrated that ASKP1240, which is...
8.
Shimizu K, Konno S, Ozaki M, Umezawa K, Yamashita K, Todo S, et al.
Clin Exp Allergy
. 2012 Jul;
42(8):1273-81.
PMID: 22805475
Background: Dehydroxymethylepoxyquinomicin (DHMEQ) is a newly developed compound that inhibits nuclear factor κB activation and is reported to ameliorate animal models of various inflammatory diseases without significant adverse effects. Because...
9.
Einama T, Homma S, Kamachi H, Kawamata F, Takahashi K, Takahashi N, et al.
Br J Cancer
. 2012 May;
107(1):137-42.
PMID: 22644300
Background: Mesothelin is expressed in various types of malignant tumour, and we recently reported that expression of mesothelin was related to an unfavourable patient outcome in pancreatic ductal adenocarcinoma. In...
10.
Oura T, Yamashita K, Suzuki T, Fukumori D, Watanabe M, Hirokata G, et al.
Am J Transplant
. 2012 Mar;
12(7):1740-54.
PMID: 22420525
Blockade of the CD40-CD154 costimulatory signal is an attractive strategy for immunosuppression and tolerance induction in organ transplantation. Treatment with anti-CD154 monoclonal antibodies (mAbs) results in potent immunosuppression in nonhuman...